Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (151-160 of 407) with videos related to

Pageof 41
Sort By:
Vaccine|April 15, 2014
Two-dose strategies for human papillomavirus vaccination: how well do they need to protect?Mark Jit, Yoon Hong Choi, Jean-François Laprise, et al.
The Lancet. Public Health|April 26, 2025
Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling studyChaofan Wang, Xiaozhen Lai, Kaja Abbas, et al.
BMC Medicine|May 17, 2011
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness modelsMark Jit, Nadia Demarteau, Elamin Elbasha, et al.
Vaccine|September 10, 2013
Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysisJanna K Breteler, John S Tam, Mark Jit, et al.
The Lancet. Global Health|December 15, 2022
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysisÉlodie Bénard, Mélanie Drolet, Jean-François Laprise, et al.
The Lancet. Public Health|December 10, 2020
Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling studyTimothy W Russell, Joseph T Wu, Sam Clifford, et al.
Epidemics|July 28, 2022
Determinants of RSV epidemiology following suppression through pandemic contact restrictionsMihaly Koltai, Fabienne Krauer, David Hodgson, et al.
The Lancet. Infectious Diseases|August 28, 2012
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisTalía Malagón, Mélanie Drolet, Marie-Claude Boily, et al.
BMC Medicine|July 3, 2023
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-makingRaymond Hutubessy, Jeremy A Lauer, Birgitte Giersing, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 10, 2013
Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisionsRaymond Oppong, Mark Jit, Richard D Smith, et al.
Pageof 41

Showing results (151-160 of 407) with videos related to

Sort By:
Pageof 41
Vaccine|April 15, 2014
Two-dose strategies for human papillomavirus vaccination: how well do they need to protect?Mark Jit, Yoon Hong Choi, Jean-François Laprise, et al.
The Lancet. Public Health|April 26, 2025
Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling studyChaofan Wang, Xiaozhen Lai, Kaja Abbas, et al.
BMC Medicine|May 17, 2011
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness modelsMark Jit, Nadia Demarteau, Elamin Elbasha, et al.
Vaccine|September 10, 2013
Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysisJanna K Breteler, John S Tam, Mark Jit, et al.
The Lancet. Global Health|December 15, 2022
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysisÉlodie Bénard, Mélanie Drolet, Jean-François Laprise, et al.
The Lancet. Public Health|December 10, 2020
Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling studyTimothy W Russell, Joseph T Wu, Sam Clifford, et al.
Epidemics|July 28, 2022
Determinants of RSV epidemiology following suppression through pandemic contact restrictionsMihaly Koltai, Fabienne Krauer, David Hodgson, et al.
The Lancet. Infectious Diseases|August 28, 2012
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisTalía Malagón, Mélanie Drolet, Marie-Claude Boily, et al.
BMC Medicine|July 3, 2023
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-makingRaymond Hutubessy, Jeremy A Lauer, Birgitte Giersing, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 10, 2013
Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisionsRaymond Oppong, Mark Jit, Richard D Smith, et al.
Pageof 41